咨询与建议

限定检索结果

文献类型

  • 1 篇 期刊文献

馆藏范围

  • 1 篇 电子文献
  • 0 种 纸本馆藏

日期分布

学科分类号

  • 1 篇 医学
    • 1 篇 临床医学

主题

  • 1 篇 therapy
  • 1 篇 precisely
  • 1 篇 chemotherapy

机构

  • 1 篇 anticancer inc. ...
  • 1 篇 department of pa...
  • 1 篇 department of su...
  • 1 篇 department of ga...
  • 1 篇 basic research l...
  • 1 篇 division of hema...
  • 1 篇 division of surg...

作者

  • 1 篇 tasuku kiyuna
  • 1 篇 takashi chishima
  • 1 篇 kentaro igarashi
  • 1 篇 ryusei matsuyama
  • 1 篇 itaru endo
  • 1 篇 sintawat wangsir...
  • 1 篇 shree ram singh
  • 1 篇 robert m.hoffman
  • 1 篇 scott d.nelson
  • 1 篇 yunfeng li
  • 1 篇 takashi murakami
  • 1 篇 arun s.singh
  • 1 篇 masashi momiyama
  • 1 篇 sahar razmjooei
  • 1 篇 fritz c.eilber
  • 1 篇 zhiying zhang
  • 1 篇 yukihiko hiroshi...
  • 1 篇 tara a.russell
  • 1 篇 sang nam yoon
  • 1 篇 kei kawaguchi

语言

  • 1 篇 英文
检索条件"作者=Masuyo Miyake"
1 条 记 录,以下是1-10 订阅
排序:
Patient-derived orthotopic xenograft models for cancer of unknown primary precisely distinguish chemotherapy,and tumor-targeting *** A1-R is superior to first-line chemotherapy
收藏 引用
Signal Transduction and Targeted Therapy 2018年 第1期3卷 220-225页
作者: Kentaro miyake Tasuku Kiyuna masuyo miyake Kei Kawaguchi Sang Nam Yoon Zhiying Zhang Kentaro Igarashi Sahar Razmjooei Sintawat Wangsiricharoen Takashi Murakami Yunfeng Li Scott D.Nelson Tara A.Russell Arun S.Singh Yukihiko Hiroshima Masashi Momiyama Ryusei Matsuyama Takashi Chishima Shree Ram Singh Itaru Endo Fritz C.Eilber Robert M.Hoffman AntiCancer Inc.San DiegoCAUSA Department of Surgery University of CaliforniaSan DiegoCAUSA Department of Gastroenterological Surgery Yokohama City University Graduate School of MedicineYokohamaJapan Department of Pathology University of CaliforniaLos AngelesCAUSA Division of Surgical Oncology University of CaliforniaLos AngelesCAUSA Division of Hematology-Oncology University of CaliforniaLos AngelesCAUSA Basic Research Laboratory National Cancer InstituteFrederickMDUSA
Cancer of unknown primary(CUP)is a recalcitrant disease with poor prognosis because it lacks standard first-line *** consists of diverse malignancy groups,making personalized precision therapy *** present study aimed ... 详细信息
来源: 维普期刊数据库 维普期刊数据库 评论